A detailed history of J.Safra Asset Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, J.Safra Asset Management Corp holds 721 shares of JNJ stock, worth $104,581. This represents 0.01% of its overall portfolio holdings.

Number of Shares
721
Previous 721 -0.0%
Holding current value
$104,581
Previous $105,000 10.48%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$144.38 - $157.78 $47,067 - $51,436
-326 Reduced 31.14%
721 $105,000
Q1 2024

May 09, 2024

BUY
$155.22 - $162.74 $44,392 - $46,543
286 Added 37.58%
1,047 $165,000
Q4 2023

Feb 02, 2024

BUY
$145.6 - $158.88 $5,824 - $6,355
40 Added 5.55%
761 $119,000
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $108,907 - $129,967
721 New
721 $111,000
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $1,613 - $1,795
-10 Reduced 7.87%
117 $0
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $20,083 - $22,807
127 New
127 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.